Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,753.70
(
0.00%
)
News Focus
News Focus
Post# of 518959
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27906
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: GAB post# 201193

Monday, 07/15/2019 10:57:59 AM

Monday, July 15, 2019 10:57:59 AM

Post# of 518959
Developing a drug with similar MOA to those Anavex own would be a lengthy process with the risk of being late and infringing on IP.

Acquisition or partnership would seem more a likely solution for a BP like Eisai.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News